Clinical Trial Update: Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating ketamine as an alternative treatment to electroconvulsive therapy for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Pouya Movahed Rad | Conditions: Depressive Disorder, Major | Phase 2, Phase 3 | Status: COMPLETED